Nrp1 has been previously proposed as a cell marker for thymic-derived Treg cells (39); but its expression has also been described on T cells during allogeneic skin graft rejection (22), sepsis (40), IL-10 deficiency (41), and anti-tumor immune responses (42, 43). This evidence concerns the gene IL10 and neoplasm.